scholarly article | Q13442814 |
P2093 | author name string | M Takeuchi | |
D V Goeddel | |||
H B Shu | |||
P2860 | cites work | Molecular cloning and expression of a receptor for human tumor necrosis factor | Q24303604 |
Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes | Q24315805 | ||
TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 | ||
A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor | Q24318280 | ||
The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation | Q24318742 | ||
TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex | Q24329065 | ||
Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation | Q27732032 | ||
The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins | Q28117866 | ||
Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection | Q28509078 | ||
Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor | Q28512161 | ||
Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes | Q28593744 | ||
Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice | Q28593915 | ||
TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B | Q29618096 | ||
The Fas death factor | Q29620461 | ||
The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death | Q29620519 | ||
Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific | Q33336314 | ||
Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor | Q33903826 | ||
A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins | Q33909940 | ||
Two TNF receptors | Q35231014 | ||
Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level | Q36404676 | ||
Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system | Q36739112 | ||
The two different receptors for tumor necrosis factor mediate distinct cellular responses | Q37609601 | ||
Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity | Q37896220 | ||
Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades | Q38326175 | ||
Tumor necrosis, cachexia, shock, and inflammation: a common mediator | Q39532135 | ||
A novel domain within the 55 kd TNF receptor signals cell death | Q41528172 | ||
A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen | Q41553101 | ||
Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences | Q41729888 | ||
Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor | Q41747117 | ||
Negative selection of thymocytes. A novel polymerase chain reaction-based molecular analysis detects requirements for macromolecular synthesis | Q44243483 | ||
Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death | Q46725238 | ||
Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects | Q59707705 | ||
Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation | Q67854330 | ||
Tumor necrosis factors: gene structure and biological activities | Q68759964 | ||
Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor kappa B and induction of human cytomegalovirus enhancer | Q72287816 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 13973-8 | |
P577 | publication date | 1996-11-26 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex | |
P478 | volume | 93 |
Q58862452 | A birthday gift for TRADD |
Q22254604 | A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction |
Q36071998 | A novel role for RIP1 kinase in mediating TNFα production |
Q28202445 | A novel zinc finger protein interacts with receptor-interacting protein (RIP) and inhibits tumor necrosis factor (TNF)- and IL1-induced NF-kappa B activation |
Q28187818 | A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha |
Q98154728 | A simple and highly efficient method for multi-allelic CRISPR-Cas9 editing in primary cell cultures |
Q28285612 | ASK1 is essential for JNK/SAPK activation by TRAF2 |
Q48615547 | Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration |
Q28139462 | Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP |
Q35083907 | Acute tumor necrosis factor-alpha-induced liver injury in the absence of tumor necrosis factor receptor-associated factor 1 gene expression |
Q41835791 | Assembly and regulation of the CD40 receptor complex in human B cells |
Q35925874 | Assembly of post-receptor signaling complexes for the tumor necrosis factor receptor superfamily |
Q36485042 | Association of TRAF2 with the short form of cellular FLICE-like inhibitory protein prevents TNFR1-mediated apoptosis |
Q35555309 | Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha |
Q24609324 | Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis |
Q41516352 | BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats. |
Q36591473 | BIRC3 is a novel driver of therapeutic resistance in Glioblastoma |
Q39224370 | Baculoviral inhibitors of apoptosis repeat containing (BIRC) proteins fine-tune TNF-induced nuclear factor κB and c-Jun N-terminal kinase signalling in mouse pancreatic beta cells. |
Q35886664 | Baculovirus inhibitor of apoptosis functions at or upstream of the apoptotic suppressor P35 to prevent programmed cell death |
Q46203326 | Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis. |
Q36954601 | Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation |
Q24315042 | Casper is a FADD- and caspase-related inducer of apoptosis |
Q34082790 | Cell death control in lymphocytes. |
Q41554119 | Cell death induction by receptors of the TNF family: towards a molecular understanding. |
Q34540067 | Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis |
Q38530635 | Cloaked in ubiquitin, a killer hides in plain sight: the molecular regulation of RIPK1. |
Q24317322 | Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1 |
Q32053895 | Construction of a modular yeast two-hybrid cDNA library from human EST clones for the human genome protein linkage map. |
Q34234140 | Cytokine signaling and Epstein-Barr virus-mediated cell transformation |
Q26779054 | DDX3, a potential target for cancer treatment |
Q39940614 | Death receptor-induced activation of initiator caspase 8 is antagonized by serine/threonine kinase PAK4. |
Q33690256 | Death signal transduction induced by co-immobilized TNF-α plus IFN-γ and the development of polymeric anti-cancer drugs |
Q47933765 | Death-inducing functions of ligands of the tumor necrosis factor family: a Sanhedrin verdict |
Q43543078 | Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1. |
Q42389083 | Differential Regulation of Bcl-xL Gene Expression by Corticosterone, Progesterone, and Retinoic Acid |
Q24294565 | Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases |
Q40375014 | Distinct role of calmodulin and calmodulin-dependent protein kinase-II in lipopolysaccharide and tumor necrosis factor-alpha-mediated suppression of apoptosis and antiapoptotic c-IAP2 gene expression in human monocytic cells |
Q29618716 | Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice |
Q41020511 | Effect of gene transfer of tumor necrosis factor receptors into human lung carcinoma cell line |
Q40956523 | Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice |
Q28207830 | Endogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosis |
Q37343955 | Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2. |
Q47716037 | Epidermal signal transduction and transcription factor activation in activated keratinocytes. |
Q24516975 | Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2 |
Q47699242 | Expression of FK506-binding protein 51 (FKBP51) in Mycosis fungoides |
Q46606781 | Expressions of tumor necrosis factor-α, its receptor I, II and receptor-associated factor 2 in the porcine corpus luteum during the estrous cycle and early pregnancy |
Q28187584 | FLASH coordinates NF-kappa B activity via TRAF2 |
Q44422902 | Fas-associated Death Domain Protein and Caspase-8 Are Not Recruited to the Tumor Necrosis Factor Receptor 1 Signaling Complex during Tumor Necrosis Factor-induced Apoptosis |
Q38691490 | Formation and removal of poly-ubiquitin chains in the regulation of tumor necrosis factor-induced gene activation and cell death |
Q28567626 | Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death |
Q41707879 | Free radicals, calcium, and the synaptic plasticity-cell death continuum: emerging roles of the transcription factor NF kappa B. |
Q28137773 | From receptors to stress-activated MAP kinases |
Q36453363 | Gene expression profiling in human autoimmunity. |
Q28207670 | Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1 |
Q22003914 | Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth |
Q24323286 | Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1 |
Q24533921 | Human IAP-like protein regulates programmed cell death downstream of Bcl-xL and cytochrome c |
Q24300707 | IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis |
Q24300734 | IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis |
Q37302745 | IAP-targeted therapies for cancer |
Q39138078 | IAPs and Cell Death |
Q37148694 | IAPs: what's in a name? |
Q28245341 | Identification and characterization of an IkappaB kinase |
Q28200039 | Identification of XAF1 as an antagonist of XIAP anti-Caspase activity |
Q40591236 | Identification of a ZU5 and death domain-containing inhibitor of NF-kappaB. |
Q28199348 | Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2 |
Q34268863 | Identification of a nuclear protein that promotes NF-κB activation |
Q24321594 | Identification of an antiapoptotic protein complex at death receptors |
Q40258580 | Inducible GBP5 Mediates the Antiviral Response via Interferon-Related Pathways during Influenza A Virus Infection. |
Q40251263 | Inducible Rubicon facilitates viral replication by antagonizing interferon production |
Q33632016 | Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins. |
Q38310679 | Inflammatory versus proliferative processes in epidermis. Tumor necrosis factor alpha induces K6b keratin synthesis through a transcriptional complex containing NFkappa B and C/EBPbeta |
Q36583948 | Inhibition of reaper-induced apoptosis by interaction with inhibitor of apoptosis proteins (IAPs). |
Q33773613 | Inhibitor of apoptosis proteins physically interact with and block apoptosis induced by Drosophila proteins HID and GRIM. |
Q34223547 | Inositol 1,3,4-trisphosphate 5/6-kinase inhibits tumor necrosis factor-induced apoptosis |
Q40858627 | Interaction of Drosophila inhibitors of apoptosis with thick veins, a type I serine/threonine kinase receptor for decapentaplegic |
Q24291474 | Interchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis signaling |
Q36597952 | Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms. |
Q23912832 | Involvement of 5'-flanking kB-like sites within bcl-x gene in silica-induced bcl-x expression |
Q45743372 | Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha -, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene |
Q24570128 | Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls |
Q34270866 | Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC. |
Q40752073 | Lack of requirement of STAT1 for activation of nuclear factor-kappaB, c-Jun NH2-terminal protein kinase, and apoptosis by tumor necrosis factor-alpha |
Q37459028 | Long-term Activation of c-Jun N-terminal Kinase through Receptor Interacting Protein is Associated with DNA Damage-induced Cell Death |
Q30432425 | Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans |
Q57816326 | MicroRNA-647 promotes the therapeutic effectiveness of argon-helium cryoablation and inhibits cell proliferation through targeting TRAF2 via the NF-κB signaling pathway in non-small cell lung cancer |
Q99616984 | Modulating TRADD to restore cellular homeostasis and inhibit apoptosis |
Q29619302 | NF-kappaB at the crossroads of life and death |
Q40568401 | NF-kappaB-mediated IAP expression induces resistance of intestinal epithelial cells to apoptosis after polyamine depletion |
Q34127458 | Natural products as targeted modulators of the nuclear factor-kappaB pathway |
Q38559586 | Necroptosis: A new way of dying? |
Q37801950 | New developments on the TNFα-mediated signalling pathways |
Q38166953 | New paradigms in inflammatory signaling in vascular endothelial cells |
Q36325686 | Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms |
Q36851742 | Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. |
Q40533310 | Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2. |
Q50526571 | Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions. |
Q34619889 | Peripheral noxious stimulation reduces withdrawal threshold to mechanical stimuli after spinal cord injury: role of tumor necrosis factor alpha and apoptosis |
Q34139073 | Polyubiquitinated tristetraprolin protects from TNF-induced, caspase-mediated apoptosis |
Q34007024 | Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin |
Q24303616 | RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation |
Q55454646 | RIG-I-Like Receptors as Novel Targets for Pan-Antivirals and Vaccine Adjuvants Against Emerging and Re-Emerging Viral Infections. |
Q39600014 | Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases. |
Q34616595 | Recent advances in understanding NF-kappaB regulation |
Q40555067 | Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro |
Q34274842 | Receptor-mediated choreography of life and death. |
Q28141339 | Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation |
Q22001513 | Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction |
Q35480734 | Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussion |
Q37009989 | Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity |
Q35920998 | Regulation of NF-κB by the CARD proteins |
Q38152946 | Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death |
Q37628447 | Regulation of death receptor signaling by the ubiquitin system |
Q56891449 | Regulation of innate and adaptive antitumor immunity by IAP antagonists |
Q92923628 | Ripoptocide - A Spark for Inflammation |
Q33784729 | Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression |
Q38189358 | Role of the TWEAK-Fn14-cIAP1-NF-κB Signaling Axis in the Regulation of Myogenesis and Muscle Homeostasis |
Q28203033 | SINK Is a p65-interacting Negative Regulator of NF-κB-dependent Transcription |
Q39375981 | Saikosaponin-d Enhances the Anticancer Potency of TNF-α via Overcoming Its Undesirable Response of Activating NF-Kappa B Signalling in Cancer Cells |
Q24630120 | Sam68 is required for both NF-κB activation and apoptosis signaling by the TNF receptor |
Q30662715 | Screening from a subtracted embryonic chick hindbrain cDNA library: identification of genes expressed during hindbrain, midbrain and cranial neural crest development |
Q44872226 | Selective regulation by delta-PKC and PI 3-kinase in the assembly of the antiapoptotic TNFR-1 signaling complex in neutrophils |
Q41724478 | Signal transduction through NF-kappa B. |
Q33693806 | Signaling to NF-kappaB: regulation by ubiquitination |
Q44762625 | Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells |
Q40621223 | Soluble IL-6 Receptor and IL-27 Subunit p28 Protein Complex Mediate the Antiviral Response through the Type III IFN Pathway |
Q24539054 | Stress-induced decrease in TRAF2 stability is mediated by Siah2 |
Q48906591 | Structural biology of tumor necrosis factor demonstrated for undergraduates instruction by computer simulation. |
Q36580820 | Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control |
Q24292181 | T2BP, a novel TRAF2 binding protein, can activate NF-kappaB and AP-1 without TNF stimulation |
Q22254711 | T6BP, a TRAF6-interacting protein involved in IL-1 signaling |
Q54439940 | TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling. |
Q37948115 | TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer |
Q30578474 | TNF receptor associated factors in cytokine signaling. |
Q30453341 | TNF receptors regulate vascular homeostasis in zebrafish through a caspase-8, caspase-2 and P53 apoptotic program that bypasses caspase-3 |
Q21093232 | TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease |
Q24292505 | TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2 |
Q28203709 | TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90 |
Q39832953 | TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling |
Q63976848 | TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy |
Q83300040 | TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells |
Q48366195 | TRADD, TRAF2, RIP1 and TAK1 are required for TNF-α-induced pro-labour mediators in human primary myometrial cells. |
Q36361121 | TRAF1 gene polymorphism correlates with the titre of Gp210 antibody in patients with primary biliary cirrhosis |
Q43168654 | TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis |
Q43170389 | TRAF2 is a biologically important necroptosis suppressor |
Q36624553 | TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1 |
Q39857832 | TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells |
Q24314392 | TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis |
Q28584897 | Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation |
Q28115962 | Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma |
Q90395021 | Targeting XIAP for Promoting Cancer Cell Death-The Story of ARTS and SMAC |
Q37855868 | Targeting inhibitor of apoptosis proteins for therapeutic intervention. |
Q45951863 | The CXXC finger 5 protein is required for DNA damage-induced p53 activation. |
Q39125509 | The Drosophila inhibitor of apoptosis protein DIAP2 functions in innate immunity and is essential to resist gram-negative bacterial infection |
Q24646694 | The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB |
Q24554457 | The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation |
Q42148237 | The RING domain of TRAF2 plays an essential role in the inhibition of TNFalpha-induced cell death but not in the activation of NF-kappaB. |
Q28190485 | The TNF receptor 1: a split personality complex |
Q28198125 | The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators |
Q24532851 | The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases |
Q35964780 | The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation |
Q73745042 | The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation |
Q37989135 | The emerging role of linear ubiquitination in cell signaling |
Q46200610 | The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2. |
Q35591690 | The inhibitors of apoptosis: there is more to life than Bcl2. |
Q22009927 | The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation |
Q52952279 | The invasive phenotype of Shigella flexneri directs a distinct gene expression pattern in the human intestinal epithelial cell line Caco-2. |
Q35902423 | The protein structures that shape caspase activity, specificity, activation and inhibition |
Q39596927 | The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation |
Q34102964 | The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies |
Q28293167 | The role of c-FLIP in modulation of CD95-induced apoptosis |
Q27619945 | The structural basis for the recognition of diverse receptor sequences by TRAF2 |
Q28140478 | The ubiquitin-homology protein, DAP-1, associates with tumor necrosis factor receptor (p60) death domain and induces apoptosis |
Q59707693 | The yeast two-hybrid screening technique and its use in the study of protein-protein interactions in apoptosis |
Q35192167 | Thermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetry |
Q23913393 | Time-dependent apoptosis of alveolar macrophages from rats exposed to bleomycin: involvement of TNF receptor 2 |
Q73649342 | Tolerance to fumonisin toxicity in a mouse strain lacking the P75 tumor necrosis factor receptor |
Q58793110 | Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways |
Q33864445 | Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis |
Q28575022 | Tumor necrosis factor receptor 1 and its signaling intermediates are recruited to lipid rafts in the traumatized brain |
Q40626565 | Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation |
Q34135071 | Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. |
Q34185821 | Tumor necrosis factor signaling. |
Q35791667 | Tumor necrosis factor-alpha acts as a complete mitogen for primary rat hepatocytes |
Q42825963 | Tumor necrosis factor-alpha mediated activation of signal transduction cascades and transcription factors in 3T3-L1 adipocytes |
Q34071248 | Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. |
Q35739622 | UVB-induced association of tumor necrosis factor (TNF) receptor 1/TNF receptor-associated factor-2 mediates activation of Rel proteins |
Q26998711 | Ubiquitin in the immune system |
Q33744532 | Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response |
Q48453757 | When Pain Hurts: Nociceptive Stimulation Induces a State of Maladaptive Plasticity and Impairs Recovery after Spinal Cord Injury. |
Q24533501 | XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway |
Q40227188 | ZNT7 binds to CD40 and influences CD154-triggered p38 MAPK activity in B lymphocytes-a possible regulatory mechanism for zinc in immune function |
Q27345421 | cIAP-1 controls innate immunity to C. pneumoniae pulmonary infection |
Q36574102 | ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein |
Q36674736 | γ-Secretase Activity Is Required for Regulated Intramembrane Proteolysis of Tumor Necrosis Factor (TNF) Receptor 1 and TNF-mediated Pro-apoptotic Signaling. |
Search more.